![Nigel Pitchford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nigel Pitchford
Directeur/Membre du Conseil chez
Touchstone Innovations Businesses LLP
Profil
Nigel Aaron Pitchford currently works at IP2IPO Company Maker Ltd., as Director, Downing Ventures, as Partner and Head of Healthcare Ventures from 2022, and Touchstone Innovations Businesses LLP, as Principal from 2012.
Dr. Pitchford also formerly worked at Ieso Digital Health Ltd., as Chief Executive Officer from 2018 to 2022, Touchstone Innovations Ltd., as Executive Director & Chief Investment Officer from 2013 to 2017, Oxford Immunotec Global Ltd., as Independent Director, Pulmagen Therapeutics (Synergy) Ltd., as Non-Executive Director, ApaTech Ltd., as Director, Immatics Biotechnologies GmbH, as Director-Supervisory Board, Oxford Immunotec Ltd., as Director, IP2IPO Innovations Ltd., as Director, Nexeon Ltd., as Director from 2017 to 2018, Veryan Medical Ltd., as Director, Touchstone Innovations Investments Ltd., as Director from 2012 to 2018, Jazz Pharmaceuticals UK Ltd., as Director, Veryan Holdings Ltd., as Director from 2012 to 2018, Hotel Bookings International Ltd., as Director, Epsilon-3 Bio Ltd, as Director, Ieso Digital Health Ltd., as Director, Abzena Ltd., as Non-Executive Director from 2014 to 2018, Oxular Ltd., as Director, IDEA AG, as Member-Supervisory Board, Esprit Capital Partners LLP, as Partner from 2010 to 2011, 3i Venture Capital, as Partner from 1997 to 2009, Touchstone Innovations Investment Management Ltd., as Chief Investment Officer, Encore Ventures LLP, as Partner from 2009 to 2012, and o2h Ltd, as Venture Partner.
Dr. Pitchford received his Masters Business Admin degree in 1997 from Warwick Business School, undergraduate degree in 1991 from the University of Oxford, and doctorate degree in 1994 from the University of Durham.
Postes actifs de Nigel Pitchford
| Sociétés | Poste | Début |
|---|---|---|
Touchstone Innovations Businesses LLP
 Touchstone Innovations Businesses LLP Investment ManagersFinance Provides investment advice | Directeur/Membre du Conseil | 23/04/2012 |
IP2IPO Company Maker Ltd. | Directeur/Membre du Conseil | - |
Downing Ventures
 Downing Ventures Investment ManagersFinance Downing Ventures invests in companies located in the United Kingdom. The firm focuses on companies with operations in the healthcare sector. It participates in early and growth stage capital transactions. | Private Equity Investor | 01/06/2022 |
Anciens postes connus de Nigel Pitchford
| Sociétés | Poste | Fin |
|---|---|---|
Ieso Digital Health Ltd.
 Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Provides Internet enabled mental health services to health providers, private individuals and businesses | Directeur Général | 15/06/2022 |
| ABZENA PLC | Directeur/Membre du Conseil | 12/10/2018 |
Veryan Holdings Ltd.
 Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which provides research and development services for clinical trails of novel vascular devices | Directeur/Membre du Conseil | 03/10/2018 |
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Operates as an eye drug development company | Directeur/Membre du Conseil | 28/02/2018 |
Nexeon Ltd.
 Nexeon Ltd. Electrical ProductsProducer Manufacturing Develops novel battery technology and silicon anodes | Directeur/Membre du Conseil | 10/02/2018 |
Formation de Nigel Pitchford
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Touchstone Innovations Ltd.
 Touchstone Innovations Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Oxford Immunotec Global Ltd.
 Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Provides diagnostic and innovative tests in the field of immunology | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Downing Ventures
Downing Ventures Investment ManagersFinance Downing Ventures invests in companies located in the United Kingdom. The firm focuses on companies with operations in the healthcare sector. It participates in early and growth stage capital transactions. | Finance |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Commercial Services |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology Provides bone graft technologies | Health Technology |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology Develops pain therapeutics and biopharmaceutical drugs | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Health Technology |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
Molten Ventures (Private Equity)
 Molten Ventures (Private Equity) Investment ManagersFinance Esprit Capital Partners invests in companies located in Europe with valuation from USD 50m-1 billion. The firm focuses on companies operating in the fields of consumer technology, digital Health & wellness, Ai, deeptech & hardware, cloud and enterprise & Saas. It provides financing for early, growth and secondary capital requirements. It also makes fund of funds and follow on investments. | Finance |
3i Venture Capital
 3i Venture Capital Investment ManagersFinance 3i VC is an active manager which works as a global team to select approximately twenty early- to late-stage investments per year. They aim to invest in companies with exceptional leadership, entrepreneurial flair, proven technical and business expertise, innovative technology and the vision to create a new market or gain significant share of an existing market. The firm prefers to lead or co-lead investments, and selects opportunities where they can create and realize significant value, take board seats and achieve exits via trade sales or IPOs. They target the healthcare, communications, software and ESAT (electronics, semiconductors and advanced technologies) sectors in Europe, the US and Asia. They invest in a series of funding rounds, separating 'first investments' (in businesses where 3i is not already invested) and 'further investments'. 3i VC actively supports their investee companies, making introductions and offering strategic guidance to accelerate their success. The majority of the firm's venture capital investment is made directly from 3i's balance sheet. | Finance |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance IIIM is an active manager which invests in technology businesses based on intellectual property from Imperial College. The company also invests in companies that have been through the incubation process managed by the Imperial Innovations' New Ventures team. The firm leads or co-leads investment rounds in technology companies across all stages of development in the healthcare, energy, environment and emerging technology sectors. Companies seeking first round funding and beyond are expected to have demonstrated that they have recruited of an experienced CEO and CTO, have a functioning board including an experienced Chairman and at least one non-executive director appointed by IIIM, have financial controls and responsible financial management, have resolved initial intellectual property technical risk, have a clear, credible and commercial business plan and have identified a location for the company to achieve full independence IIIM works toward exits through trade sales, mergers or IPOs. | Finance |
Nexeon Ltd.
Nexeon Ltd. Electrical ProductsProducer Manufacturing Develops novel battery technology and silicon anodes | Producer Manufacturing |
Veryan Medical Ltd.
 Veryan Medical Ltd. BiotechnologyHealth Technology Develops and commercializes novel vascular stent technology | Health Technology |
Touchstone Innovations Investments Ltd.
 Touchstone Innovations Investments Ltd. Financial ConglomeratesFinance Alternative investment manager | Finance |
Touchstone Innovations Businesses LLP
Touchstone Innovations Businesses LLP Investment ManagersFinance Provides investment advice | Finance |
Encore Ventures LLP
 Encore Ventures LLP Investment ManagersFinance Encore is a hands-on manager which focuses exclusively on acquiring secondary portfolios of investments from existing private equity groups. They have particular experience in companies in the components & systems, mobile & software, Internet & services and medtech sectors. The firm aims to acquire portfolios of assets on a deal-by-deal basis with financial backing from other investors. | Finance |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets late-stage oncology, oncology supportive care and critical care products | Health Technology |
Veryan Holdings Ltd.
Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which provides research and development services for clinical trails of novel vascular devices | Commercial Services |
Hotel Bookings International Ltd. | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Provides compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders | Health Technology |
Ieso Digital Health Ltd.
Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Provides Internet enabled mental health services to health providers, private individuals and businesses | Commercial Services |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
IP2IPO Company Maker Ltd. | |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Operates as an eye drug development company | Health Technology |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
